Načítá se...
The concept of ‘borderline resectable’ pancreatic cancer: limited foundations and limited future?
Pancreatic ductal adenocarcinoma (PDAC) is traditionally treated by a surgery-first approach. The development and adoption of the concept of borderline resectable PDAC, which extends the role of surgery, is based on the proposition that neoadjuvant therapy (NAT) will increase the resection rate, mar...
Uloženo v:
| Vydáno v: | J Gastrointest Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334050/ https://ncbi.nlm.nih.gov/pubmed/28280624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.12.06 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|